| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 26 May 2026 | 28 Apr 2026 |
| Jubilant Ingrevia Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 inter alia to consider and approve Intimation of Board Meeting - May 26 2026 | ||
| Board Meeting | 4 Feb 2026 | 19 Jan 2026 |
| Quarterly Results Jubilant Ingrevia Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2026 ,inter alia, to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended December 31, 2025 . Jubilant Ingrevia Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2026 ,inter alia, to consider and approve Update on board meeting - Proposal for payment of Interim Dividend for the financial year 2026, if any Update on board meeting - Proposal for payment of Interim Dividend for the financial year 2026, if any Outcome of Board Meeting held on February 04, 2026 (As per BSE Announcement dated on: 04.02.2026) | ||
| Board Meeting | 27 Oct 2025 | 13 Oct 2025 |
| Jubilant Ingrevia Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2025 inter alia to consider and approve Unaudited (Standalone & Consolidated) Financial Results for the quarter and half year ending on September 30 2025 Grant of Options/ Restricted Stock Units (RSUs) under Jubilant Ingrevia Employees Stock Option Plan 2021 (As per BSE Announcement dated on: 27.10.2025) Outcome of Board Meeting held on October 27, 2025 (As per BSE Announcement dated on: 27.10.2025) | ||
| Board Meeting | 31 Jul 2025 | 23 Jul 2025 |
| Jubilant Ingrevia Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2025 inter alia to consider and approve the unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30 2025 Outcome of Board Meeting held on July 31, 2025 Unaudited financial results for the quarter ended June 30, 2025 (As Per BSE Announcement Dated on :31.07.2025) | ||
The board approved this acquisition on December 30, 2024. The equity bought of 6.67% was from Hero Fincorp Ltd and Sunil Kant Munjal.
In Q2 FY25, the company's total EBITDA increased by 7% year on year to ₹135 Crore, up from ₹126 Crore the previous year.
The company stated that its production facility in Bharuch successfully completed its USFDA inspection with zero 483 findings.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
